[DPHARMA] YoY Annualized Quarter Result on 30-Sep-2019 [#3]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
29-Nov-2019
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2019
Quarter
30-Sep-2019 [#3]
Profit Trend
QoQ- 1.57%
YoY- 29.96%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
Annualized Quarter Result
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
Revenue 726,342 658,308 581,088 584,942 510,784 474,312 318,542 14.71%
PBT 92,672 87,808 74,248 75,826 56,010 51,961 33,573 18.42%
Tax -22,070 -21,185 -17,692 -18,173 -11,648 -11,518 -9,580 14.91%
NP 70,601 66,622 56,556 57,653 44,362 40,442 23,993 19.69%
-
NP to SH 70,601 66,622 56,556 57,653 44,362 40,829 25,156 18.75%
-
Tax Rate 23.82% 24.13% 23.83% 23.97% 20.80% 22.17% 28.53% -
Total Cost 655,741 591,685 524,532 527,289 466,421 433,869 294,549 14.26%
-
Net Worth 647,522 612,147 584,565 505,919 501,487 474,230 451,913 6.17%
Dividend
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
Div 6,348 6,278 4,639 8,994 13,197 - - -
Div Payout % 8.99% 9.42% 8.20% 15.60% 29.75% - - -
Equity
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
Net Worth 647,522 612,147 584,565 505,919 501,487 474,230 451,913 6.17%
NOSH 952,239 941,765 706,026 680,106 661,881 278,959 278,959 22.69%
Ratio Analysis
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
NP Margin 9.72% 10.12% 9.73% 9.86% 8.69% 8.53% 7.53% -
ROE 10.90% 10.88% 9.67% 11.40% 8.85% 8.61% 5.57% -
Per Share
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
RPS 76.28 69.90 83.50 86.71 77.41 170.03 114.19 -6.50%
EPS 7.45 7.08 8.21 8.65 6.79 14.49 8.60 -2.36%
DPS 0.67 0.67 0.67 1.33 2.00 0.00 0.00 -
NAPS 0.68 0.65 0.84 0.75 0.76 1.70 1.62 -13.46%
Adjusted Per Share Value based on latest NOSH - 680,106
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
RPS 75.51 68.44 60.41 60.81 53.10 49.31 33.11 14.72%
EPS 7.34 6.93 5.88 5.99 4.61 4.24 2.62 18.72%
DPS 0.66 0.65 0.48 0.93 1.37 0.00 0.00 -
NAPS 0.6731 0.6364 0.6077 0.5259 0.5213 0.493 0.4698 6.17%
Price Multiplier on Financial Quarter End Date
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
Date 30/09/22 30/09/21 30/09/20 30/09/19 28/09/18 29/09/17 30/09/16 -
Price 1.30 1.81 3.16 1.40 1.23 2.20 2.06 -
P/RPS 1.70 2.59 3.78 1.61 1.59 1.29 1.80 -0.94%
P/EPS 17.53 25.59 38.88 16.38 18.30 15.03 22.84 -4.31%
EY 5.70 3.91 2.57 6.10 5.47 6.65 4.38 4.48%
DY 0.51 0.37 0.21 0.95 1.63 0.00 0.00 -
P/NAPS 1.91 2.78 3.76 1.87 1.62 1.29 1.27 7.03%
Price Multiplier on Announcement Date
30/09/22 30/09/21 30/09/20 30/09/19 30/09/18 30/09/17 30/09/16 CAGR
Date 09/11/22 18/11/21 12/11/20 29/11/19 28/11/18 17/11/17 21/11/16 -
Price 1.39 1.62 4.04 1.39 1.07 2.20 2.10 -
P/RPS 1.82 2.32 4.84 1.60 1.38 1.29 1.84 -0.18%
P/EPS 18.75 22.90 49.71 16.26 15.92 15.03 23.29 -3.54%
EY 5.33 4.37 2.01 6.15 6.28 6.65 4.29 3.68%
DY 0.48 0.41 0.17 0.96 1.87 0.00 0.00 -
P/NAPS 2.04 2.49 4.81 1.85 1.41 1.29 1.30 7.79%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment